Valuation: Precipio, Inc.

Market Cap 41.41M 36.79M 34.34M 31.3M 59.03M 3.98B 59.58M 416M 161M 2.03B 155M 152M 6.53B P/E 2024
-1.89x
P/E 2025 -102x
Enterprise Value 42.41M 37.68M 35.17M 32.05M 60.46M 4.08B 61.02M 426M 165M 2.08B 159M 156M 6.69B EV / Sales 2024
0.44x
EV / Sales 2025 1.72x
Free-Float
87.32%
Yield 2024 *
-
Yield 2025 -
1 day+1.76%
1 week-2.20%
Current month-2.32%
1 month-15.89%
3 months-8.43%
6 months-8.94%
Current year+0.65%
1 week 22.45
Extreme 22.45
24.36
1 month 22.45
Extreme 22.45
28
Current year 19.22
Extreme 19.22
33.63
1 year 16.4
Extreme 16.4
33.63
3 years 3.9
Extreme 3.9
33.63
5 years 3.9
Extreme 3.9
54.8
10 years 3.9
Extreme 3.9
8,448.01
Manager TitleAgeSince
Chief Operating Officer 41 -
Chief Tech/Sci/R&D Officer 42 01/06/2017
Chief Executive Officer 54 28/06/2017
Director TitleAgeSince
Director/Board Member 54 28/06/2017
Director/Board Member 78 26/09/2017
Director/Board Member 67 08/11/2017
Date Insider Type Main position Quantity % Market Cap. Importance
15/07/26 Free

Director

520 0.0291%
15/07/26 Free

Director

416 0.0233%
15/07/26 Free

Director

108 0.0060%
Change 5-day change 1-year change 3-year change Capi.($)
+1.76%-2.20%+10.94%+302.96% 41.41M
+0.35%-2.99%+24.73%+32.07% 242B
+1.09%-4.65%+1.77%+0.15% 150B
-2.32%-3.27%-11.53%+32.87% 138B
-1.46%-3.01%-55.73%-19.33% 61.74B
-0.05%-1.32%+11.09%+23.08% 49.08B
+0.66%+0.19%-19.29%-21.24% 47.43B
+0.66%-2.90%+20.97%+51.29% 47.3B
-3.05%-2.62%-9.13%+35.86% 44.25B
-0.08%-1.92%+32.09%+57.18% 41.78B
Average +0.02%-2.47%+0.59%+49.49% 82.27B
Weighted average by Cap. +0.15%-3.27%+3.38%+21.50%

Financials

2024 2025
Net sales 18.53M 16.47M 15.37M 14.01M 26.42M 1.78B 26.66M 186M 72.07M 911M 69.58M 68.07M 2.92B 24.05M 21.37M 19.94M 18.18M 34.28M 2.31B 34.6M 241M 93.52M 1.18B 90.29M 88.33M 3.79B
Net income -4.29M -3.81M -3.56M -3.24M -6.12M -412M -6.17M -43.05M -16.68M -211M -16.11M -15.76M -677M -363K -323K -301K -274K -517K -34.9M -522K -3.64M -1.41M -17.84M -1.36M -1.33M -57.25M
Net Debt -136K -121K -113K -103K -194K -13.07M -196K -1.36M -529K -6.68M -511K -500K -21.45M 1M 890K 831K 757K 1.43M 96.33M 1.44M 10.06M 3.9M 49.24M 3.76M 3.68M 158M
Logo Precipio, Inc.
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Employees
66
Date Price Change Volume
02/10/26 $23.13 +1.76% 22,695
01/10/26 $22.73 -4.01% 13,858
30/09/26 $23.68 +0.42% 74,242
29/09/26 $23.58 -2.20% 63,080
28/09/26 $24.11 +1.95% 72,396
  1. Stock Market
  2. Stocks
  3. PRPO Stock